InMed Pharmaceuticals (TSX:IN,OTCQX:IMLFF) confirmed that cannabinol (CBN) is the active pharmaceutical ingredient in its two product candidates under development for for epidermolysis bullosa and glaucoma.

As quoted in the press release:


InMed is leading the way in the clinical development of CBN to treat human disease.

“We are proud to be the first company to investigate cannabinol’s therapeutic potential in human clinical trials,” commented InMed CEO, Eric A. Adams. “InMed has completed more than 30 preclinical pharmacology and toxicology studies, identifying potential therapeutic advantages of CBN in specific disease models over the more common cannabinoids THC and CBD, as well as other rare variants.” Mr. Adams continued, “We are simultaneously exploring innovative biosynthetic manufacturing methods and therapeutic applications of CBN formulations to target diseases with high unmet medical need.”

Click here to read the full press release.

– Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020 inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

Keep reading... Show less

 BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) announces that it has added Advocate Roberto Chait to the Company’s Advisory Board.

Adv. Chait brings to the Company a wealth of experience in corporate and international trade law, intellectual property law, and cross border international transactions. His knowledge and expertise in these areas have been acquired representing major global clients across highly relevant industries for the Company including the Food and Beverage, Food Tech, and International Media industries.

Keep reading... Show less

The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion.

Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to fcruz@frankcruzlaw.com .

Keep reading... Show less

Progressive Planet Solutions Inc. (TSXV: PLAN) (“PLAN” or “Progressive Planet”), an emerging leader in the commercialization of natural pozzolans to reduce the carbon footprint of cement production, is pleased to announce that it has expanded the confirmed bedrock source for the nickel in soil anomaly that PLAN reported on August 5 and 17, 2020 on its 100% owned Heffley Creek  Metals and Pozzolan Property in BC.  PLAN also reports multiple samples with anomalous levels of chromium. The latest sampling has identified  a correlation between the elevated nickel and elevated chromium values.

Based on the soil survey results reported on August 5, 2020 and confirmation of a bedrock source reported on August 17, 2020 , PLAN continues its systematic rock sampling program to confirm the soil sample results and to define the limits of the nickel in bedrock anomaly.

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”) reported its fiscal 2020 financial results for the twelve-month period ended June 30, 2020. A complete set of financial statements and Management’s Discussion & Analysis has been filed at www.sedar.com. All dollar figures are quoted in Canadian dollars.

FY2020 Year End Financial Highlights

Keep reading... Show less